C.S. Mott Children's Hospital, University of Michigan, Department of Pediatrics, Division of Pediatric Critical Care, Ann Arbor, MI 48109-0243, USA.
Am J Infect Control. 2010 Oct;38(8):585-95. doi: 10.1016/j.ajic.2010.04.211.
Catheter-related bloodstream infections are an important quality performance measure and remain a significant source of added morbidity, mortality, and medical costs.
Our objectives were to assess variability in catheter-associated bloodstream infections (CA-BSI) surveillance practices, management, and attitudes/beliefs in pediatric intensive care units (PICUs) and to determine whether any correlation exists between surveillance variation and CA-BSI rates.
We used a survey of 5 health care professions at multiple institutions.
One hundred forty-six respondents from 5 professions in 16 PICUs completed surveys with a response rate of 40%. All 10 (100%) infection control departments reported inclusion or exclusion of central line types inconsistent with the Centers for Disease Control and Prevention CA-BSI definition, 5 (50%) calculated line-days inconsistently, and only 5 (50%) used a strict, written policy for classifying BSIs. Infection control departments report substantial variation in methods, timing, and resources used to screen and adjudicate BSI cases. Greater than 80% of centers report having a formal, written policy about obtaining blood cultures, although less than 80% of these address obtaining samples from patients with central venous lines, and any such policies are reportedly followed less than half of the time. Substantial variation exists in blood culturing practices, such as temperature thresholds, preemptive antipyretics, and blood sampling (volumes, number, sites, frequencies). A surveillance aggressiveness score was devised to quantify practices likely to increase identification of bloodstream infections, and there was a significant correlation between the surveillance aggressiveness score and CA-BSI rates (r = 0.60, P = .034). In assessing attitudes and beliefs, there was much greater confidence in the validity of CA-BSI as an internal/historical benchmark than as an external/peer benchmark, and the factor most commonly believed to contribute to CA-BSI occurrences was patient risk factors, not central line maintenance or insertion practices.
There is substantial variation in reported CA-BSI surveillance practices among PICUs, and more aggressive surveillance correlates to higher CA-BSI rates, which has important implications in pay-for-performance and benchmarking applications. There is a compelling opportunity to improve standardized CA-BSI surveillance to enhance the validity of this metric for interinstitutional comparisons. Health care professionals' attitudes and beliefs about CA-BSI being driven by patient risk factors would benefit from recalibration that emphasized more important drivers-such as the quality of central line insertion and maintenance.
导管相关血流感染是一个重要的质量绩效指标,仍然是发病率、死亡率和医疗费用增加的重要来源。
我们的目的是评估儿科重症监护病房(PICU)中导管相关血流感染(CA-BSI)监测实践、管理和态度/信念的变异性,并确定监测变化与 CA-BSI 率之间是否存在任何相关性。
我们使用了对多个机构的 5 种医疗保健专业人员的调查。
来自 5 个专业的 146 名 16 个 PICU 的受访者完成了调查,应答率为 40%。所有 10 个(100%)感染控制部门报告包括或排除与疾病预防控制中心 CA-BSI 定义不一致的中央线类型,5 个(50%)不一致地计算线日,只有 5 个(50%)使用严格的书面政策来分类 BSI。感染控制部门报告在筛查和裁决 BSI 病例时使用的方法、时间和资源存在很大差异。超过 80%的中心报告有关于获取血培养的正式书面政策,尽管不到 80%的政策涉及从带有中央静脉导管的患者中获取样本,而且据报道,这些政策的遵循率不到一半。血液培养实践存在很大差异,例如温度阈值、预防性退热剂和血液取样(体积、数量、部位、频率)。制定了一个监测积极性评分来量化可能增加血流感染识别的实践,并且监测积极性评分与 CA-BSI 率之间存在显著相关性(r = 0.60,P =.034)。在评估态度和信念时,人们对 CA-BSI 作为内部/历史基准的有效性比对外部/同行基准的有效性更有信心,并且被认为最常导致 CA-BSI 发生的因素是患者风险因素,而不是中央线维护或插入实践。
PICU 中报告的 CA-BSI 监测实践存在很大差异,更积极的监测与更高的 CA-BSI 率相关,这对绩效支付和基准应用具有重要意义。有一个引人注目的机会可以改进标准化的 CA-BSI 监测,以提高该指标用于机构间比较的有效性。医疗保健专业人员关于 CA-BSI 由患者风险因素驱动的态度和信念需要重新校准,强调更重要的驱动因素,例如中央线插入和维护的质量。